bey1107

Avotaciclib (BEY1107) 是一种有效和具有口服活性的 cyclin dependent kinase 1 (CDK1) 抑制剂。Avotaciclib 可用于研究局部晚期或转移性胰腺癌。

Avotaciclib trihydrochloride, also known as BEY1107, is a highly effective and orally active inhibitor of cyclin dependent kinase 1 (CDK1). This compound is particularly valuable for researching locally advanced or metastatic pancreatic cancer.

Avotaciclibhydrochloride是Avotaciclib的盐酸盐形式，具有抑制CDK1的作用。适用于治疗CDK1异常高表达的特定癌症类型，例如胰腺癌。